Close Menu
Home › Saga Diagnostics Raises $4.2M

Saga Diagnostics Raises $4.2M

Jun 11, 2019
|
staff reporter

NEW YORK (GenomeWeb) — Swedish liquid biopsy firm Saga Diagnostics said today that it has raised SEK 40 million ($4.2 million) in venture financing.

Hadean Ventures led the round with participation from existing investors including Fårö Capital and the Gunnar Nilsson Cancer Foundation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Featured Webinar

Using Next-Generation Sequencing to Detect Genomic Mutations in Hematologic Malignancies

Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
24
Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

What's Popular?

In Molecular Diagnostics

  1. USPSTF Formalizes Slightly Expanded BRCA Screening Recommendations

  2. FDA Stepping Up Actions Against PGx Testing, Forcing Some Labs to Stop Reporting Drug Information

  3. Genomind, NeuroFlow Collaborate to Provide Genetic Testing-Based Mental Health Services

  4. OpGen Progresses on Pipeline of Highly Multiplexed Drug-Resistant Bacteria Tests

    Premium

  5. Cancer Genetics Posts 15 Percent Rise in Q2 Revenues

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.